BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mark DB, Cowper PA, Anstrom KJ, Sheng S, Daniels MR, Knight JD, Baloch KN, Davidson-Ray L, Fiuzat M, Januzzi JL Jr, Whellan DJ, Piña IL, Ezekowitz JA, Adams KF, Cooper LS, O'Connor CM, Felker GM. Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure. J Am Coll Cardiol 2018;72:2551-62. [PMID: 30466512 DOI: 10.1016/j.jacc.2018.08.2184] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Chouairi F, Pacor J, Miller PE, Fuery MA, Caraballo C, Sen S, Leifer ES, Felker GM, Fiuzat M, O'Connor CM, Januzzi JL, Friedman DJ, Desai NR, Ahmad T, Freeman JV. Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT Trial. Mayo Clin Proc Innov Qual Outcomes 2021;5:447-55. [PMID: 33997640 DOI: 10.1016/j.mayocpiqo.2021.02.005] [Reference Citation Analysis]
2 Castiglione V, Aimo A, Vergaro G, Saccaro L, Passino C, Emdin M. Biomarkers for the diagnosis and management of heart failure. Heart Fail Rev 2021. [PMID: 33852110 DOI: 10.1007/s10741-021-10105-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Urbich M, Globe G, Pantiri K, Heisen M, Bennison C, Wirtz HS, Di Tanna GL. A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014-2020). Pharmacoeconomics 2020;38:1219-36. [PMID: 32812149 DOI: 10.1007/s40273-020-00952-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
4 Pahuja M, Leifer ES, Clarke JD, Ahmad T, Daubert MA, Mark DJ, Cooper L, Desvigne-Nickens P, Fiuzat M, Adams K, Ezekowitz J, Whellan DJ, Januzzi JL, O'Connor CM, Felker GM, Piña IL. Assessing race and ethnicity differences in outcomes based on GDMT and target NT-proBNP in patients with heart failure with reduced ejection fraction: An analysis of the GUIDE-IT study. Prog Cardiovasc Dis 2022:S0033-0620(22)00039-1. [PMID: 35490873 DOI: 10.1016/j.pcad.2022.04.010] [Reference Citation Analysis]
5 Berezin AE, Berezin AA. Point-of-care heart failure platform: where are we now and where are we going to? Expert Rev Cardiovasc Ther 2022. [PMID: 35588730 DOI: 10.1080/14779072.2022.2080657] [Reference Citation Analysis]
6 Chouairi F, Fuery MA, Mullan CW, Caraballo C, Sen S, Maulion C, Wilkinson ST, Surti T, McCullough M, Miller PE, Pacor J, Leifer ES, Felker GM, Velazquez EJ, Fiuzat M, O'Connor CM, Januzzi JL, Desai NR, Ahmad T. The Impact of Depression on Outcomes in Patients With Heart Failure and Reduced Ejection Fraction Treated in the GUIDE-IT Trial. J Card Fail 2021:S1071-9164(21)00244-X. [PMID: 34166799 DOI: 10.1016/j.cardfail.2021.06.008] [Reference Citation Analysis]
7 Kałużna-Oleksy M, Sawczak F, Kukfisz A, Krysztofiak H, Szczechla M, Wleklik M, Przytarska K, Dudek M, Nowak A, Straburzyńska-Migaj E, Uchmanowicz B. The Impact of Clinical, Biochemical, and Echocardiographic Parameters on the Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction. Int J Environ Res Public Health 2021;18:12448. [PMID: 34886173 DOI: 10.3390/ijerph182312448] [Reference Citation Analysis]
8 Mueller C, Mcdonald K, de Boer RA, Maisel A, Cleland JG, Kozhuharov N, Coats AJ, Metra M, Mebazaa A, Ruschitzka F, Lainscak M, Filippatos G, Seferovic PM, Meijers WC, Bayes‐genis A, Mueller T, Richards M, Januzzi JL; on behalf of the Heart Failure Association of the European Society of Cardiology. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail 2019;21:715-31. [DOI: 10.1002/ejhf.1494] [Cited by in Crossref: 113] [Cited by in F6Publishing: 88] [Article Influence: 37.7] [Reference Citation Analysis]
9 Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology 2022. [DOI: 10.1016/j.jacc.2021.12.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 27.0] [Reference Citation Analysis]
10 Reddy YNV, Borlaug BA, O’connor CM, Gersh BJ. Novel approaches to the management of chronic systolic heart failure: future directions and unanswered questions. European Heart Journal 2020;41:1764-74. [DOI: 10.1093/eurheartj/ehz364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Brunner-La Rocca HP, Sanders-van Wijk S. Guiding Heart Failure Therapy After GUIDE-IT: Back to the Drawing Board. J Am Coll Cardiol 2018;72:2563-6. [PMID: 30466513 DOI: 10.1016/j.jacc.2018.08.2185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Heidenreich PA, Fonarow GC, Opsha Y, Sandhu AT, Sweitzer NK, Warraich HJ. Economic Issues in Heart Failure in the United States. Journal of Cardiac Failure 2022. [DOI: 10.1016/j.cardfail.2021.12.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Logan JK, Mentz RJ. Targeting Natriuretic Peptide Levels in Heart Failure with Therapy: Does "X" Really Mark the Spot? Curr Heart Fail Rep 2019;16:250-6. [PMID: 31741230 DOI: 10.1007/s11897-019-00441-2] [Reference Citation Analysis]
14 Selvaraj S, Claggett B, Pozzi A, Mcmurray JJ, Jhund PS, Packer M, Desai AS, Lewis EF, Vaduganathan M, Lefkowitz MP, Rouleau JL, Shi VC, Zile MR, Swedberg K, Solomon SD. Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF. Circulation 2019;140:1369-79. [DOI: 10.1161/circulationaha.119.039920] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]